Acute kidney injury following endovascular intervention for peripheral artery disease.
Journal
The British journal of surgery
ISSN: 1365-2168
Titre abrégé: Br J Surg
Pays: England
ID NLM: 0372553
Informations de publication
Date de publication:
12 03 2021
12 03 2021
Historique:
received:
23
06
2020
revised:
21
08
2020
accepted:
27
09
2020
entrez:
12
3
2021
pubmed:
13
3
2021
medline:
29
4
2021
Statut:
ppublish
Résumé
The incidence of, and risk factors for, acute kidney injury (AKI) after endovascular intervention for peripheral artery disease (PAD) remain unknown. The aim of this study was to assess the proportion of patients who develop AKI and explore the risk factors. Prospectively collected data on patients undergoing femoropopliteal endovascular intervention for symptomatic PAD across three vascular centres were analysed. The proportion of patients developing AKI (according to the Kidney Disease Improving Global Outcomes definition) within 48 h, and the proportion developing the composite Major Adverse Kidney Events (MAKE) endpoints (death, dialysis, drop in estimated glomerular filtration rate at least 25 per cent) at 30 days (MAKE30) and remains 90 days (MAKE90) were calculated. Multivariable regression analysis was used to assess predictors of AKI, and the association between AKI and death. Some 2041 patients were included in the analysis. AKI developed in 239 patients (11.7 per cent), with 47 (2.3 per cent) requiring dialysis within 30 days, and 18 (0.9 per cent) requiring ongoing dialysis. The MAKE30 and MAKE90 composite endpoints were reached in 358 (17.5 per cent) and 449 (22.0 per cent) patients respectively. Risk factors for AKI were age, sex, congestive heart failure, chronic limb-threatening ischaemia, emergency procedure, and pre-existing chronic kidney disease. AKI, dementia, congestive heart failure, and major amputation were risk factors for medium-term mortality. AKI is a common complication after intervention for PAD and is associated with medium-term mortality.
Sections du résumé
BACKGROUND
The incidence of, and risk factors for, acute kidney injury (AKI) after endovascular intervention for peripheral artery disease (PAD) remain unknown. The aim of this study was to assess the proportion of patients who develop AKI and explore the risk factors.
METHODS
Prospectively collected data on patients undergoing femoropopliteal endovascular intervention for symptomatic PAD across three vascular centres were analysed. The proportion of patients developing AKI (according to the Kidney Disease Improving Global Outcomes definition) within 48 h, and the proportion developing the composite Major Adverse Kidney Events (MAKE) endpoints (death, dialysis, drop in estimated glomerular filtration rate at least 25 per cent) at 30 days (MAKE30) and remains 90 days (MAKE90) were calculated. Multivariable regression analysis was used to assess predictors of AKI, and the association between AKI and death.
RESULTS
Some 2041 patients were included in the analysis. AKI developed in 239 patients (11.7 per cent), with 47 (2.3 per cent) requiring dialysis within 30 days, and 18 (0.9 per cent) requiring ongoing dialysis. The MAKE30 and MAKE90 composite endpoints were reached in 358 (17.5 per cent) and 449 (22.0 per cent) patients respectively. Risk factors for AKI were age, sex, congestive heart failure, chronic limb-threatening ischaemia, emergency procedure, and pre-existing chronic kidney disease. AKI, dementia, congestive heart failure, and major amputation were risk factors for medium-term mortality.
CONCLUSION
AKI is a common complication after intervention for PAD and is associated with medium-term mortality.
Identifiants
pubmed: 33711140
pii: 6099683
doi: 10.1093/bjs/znaa057
pmc: PMC7954277
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
152-159Subventions
Organisme : British Heart Foundation
Pays : United Kingdom
Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of BJS Society Ltd. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Références
Am Heart J. 2012 May;163(5):829-34
pubmed: 22607861
J Am Coll Cardiol. 2015 Jul 28;66(4):403-69
pubmed: 25553722
J Vasc Surg. 2017 Aug;66(2):618-637
pubmed: 28735955
Rev Cardiovasc Med. 2006 Fall;7(4):177-97
pubmed: 17224862
Crit Care. 2013 Oct 11;17(5):R231
pubmed: 24119576
Angiology. 2016 Jul;67(6):556-64
pubmed: 26324203
J Am Heart Assoc. 2018 Dec 18;7(24):e011245
pubmed: 30561254
Kidney Int. 2013 Mar;83(3):372-6
pubmed: 23302721
Crit Care. 2013 Dec 12;17(6):R292
pubmed: 24330762
Am J Kidney Dis. 2019 Feb;73(2):163-173
pubmed: 30482577
Cardiorenal Med. 2015 Jun;5(3):219-28
pubmed: 26195974
BMC Med. 2004 Oct 22;2:38
pubmed: 15500690
Eur J Vasc Endovasc Surg. 2020 Jun;59(6):899-909
pubmed: 31870694
Nephron Clin Pract. 2014;127(1-4):89-93
pubmed: 25343828
Am J Med. 1997 Nov;103(5):368-75
pubmed: 9375704
BMJ. 2013 Aug 28;347:f4930
pubmed: 23985310
Catheter Cardiovasc Interv. 2005 Apr;64(4):442-8
pubmed: 15789398
Am J Nephrol. 2015;42(4):285-94
pubmed: 26495853
J Med Invest. 2018;65(1.2):116-121
pubmed: 29593180
Acta Radiol Open. 2015 Jun 24;4(6):2058460115583034
pubmed: 26346218
Stat Methods Med Res. 2007 Jun;16(3):219-42
pubmed: 17621469
J Vasc Surg. 2016 Jul;64(1):e1-e21
pubmed: 27345516
Am J Nephrol. 2012;35(4):349-55
pubmed: 22473149
Eur Heart J. 2014 Jun 14;35(23):1533-40
pubmed: 24603308
J Interv Cardiol. 2017 Jun;30(3):274-280
pubmed: 28370487
Kidney Int. 2015 Nov;88(5):1199
pubmed: 26579689
Angiology. 2015 Jul;66(6):514-8
pubmed: 25115554
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Tech Vasc Interv Radiol. 2016 Jun;19(2):91-5
pubmed: 27423989
Eur J Vasc Endovasc Surg. 2019 Jul;58(1S):S1-S109.e33
pubmed: 31182334
Can J Kidney Health Dis. 2016 Feb 26;3:5
pubmed: 26925244
BMJ. 2018 Feb 1;360:j5842
pubmed: 29419394
Circ J. 2008 Mar;72(3):427-33
pubmed: 18296840
JAMA. 2012 May 9;307(18):1941-51
pubmed: 22570462
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
J Vasc Surg. 2019 Mar;69(3):913-920
pubmed: 30292616
Circulation. 2006 Apr 11;113(14):1799-806
pubmed: 16606801
Br J Surg. 2020 Jan;107(1):20-32
pubmed: 31808552
ISRN Radiol. 2013 Sep 16;2013:496438
pubmed: 24967281
Clin J Am Soc Nephrol. 2015 Nov 6;10(11):1930-6
pubmed: 26487770
Eur J Clin Invest. 2013 May;43(5):483-90
pubmed: 23441924
Eur J Vasc Endovasc Surg. 2016 Mar;51(3):386-93
pubmed: 26460289
Acta Radiol. 2008 Jul;49(6):658-67
pubmed: 18568558
Am J Kidney Dis. 2017 Jan;69(1):18-28
pubmed: 27555107
J Am Coll Cardiol. 2011 Aug 23;58(9):907-14
pubmed: 21851878
PLoS One. 2015 Mar 23;10(3):e0121482
pubmed: 25799318
J Card Fail. 2010 May;16(5):381-9
pubmed: 20447573
J Vasc Surg. 2015 Mar;61(3):720-7
pubmed: 25499712